Immune system activity following traumatic brain injury causes additional brain damage. An investigational drug may help protect injured patients against immune-related neurodegeneration.
The findings were recently published in Acta Neuropathologica Communications. Read Paper The experimental drug, known as VG1177, is currently undergoing pre-clinical animal safety trials.
“This research has important implications for contact sports involving all ages, military trauma, and accident victims,” said Richard P. Tobin, PhD, lead author. “We are encouraged that VG1177 may be an example of a new class of agents that affect the immune system to improve the outcome of traumatic brain injuries.” Read More